Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: The prognostic value of EGFR and KRAS mutations in resected non-small cell lung cancer (NSCLC) has been reported. However, conflicting results were reported in these studies. The effect of mutations in these two genes in resected NSCLC remains controversial. METHODS: We searched Internet...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Manag Res
Egile Nagusiak: Zhang, Shi-Ming, Zhu, Qing-Ge, Ding, Xiao-Xiao, Lin, Song, Zhao, Jing, Guan, Lei, Li, Ting, He, Bing, Zhang, Hu-Qin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6138965/
https://ncbi.nlm.nih.gov/pubmed/30237741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S167578
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak